This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Intra-Cellular Therapies’s 8K filing here.
About Intra-Cellular Therapies
Intra-Cellular Therapies, Inc, a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States.
Read More
- Five stocks we like better than Intra-Cellular Therapies
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Stocks With High Short Interest Still Near Their 52-Week Highs
- Investing In Automotive Stocks
- Financial Stocks Holding Firm Near Highs: 2 Key Players to Watch
- What is a Stock Market Index and How Do You Use Them?
- Upwork Fortifies Profitability Plan With Raised Q3 Forecasts
